Transgene Biotek Ltd. - Research Center
526139 TRABI Group (X) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Sep' 24 |
Jun' 24 |
Mar' 24 |
Dec' 23 |
Sep' 23 |
Sales |
0.06 |
0.05 |
0.05 |
0.05 |
0.05 |
Operating profit |
-0.08 |
-0.41 |
-0.27 |
-0.11 |
-0.12 |
Interest |
0.02 |
0.02 |
0.03 |
0.03 |
0.03 |
Gross profit |
-0.05 |
0.22 |
-0.25 |
-0.10 |
-0.11 |
EPS (Rs) |
-0.01 |
0.03 |
-0.04 |
-0.02 |
-0.02 |
Quarterly
results in details
|
Sep' 24 |
Jun' 24 |
Mar' 24 |
Dec' 23 |
Sep' 23 |
Other income |
0.04 |
0.65 |
0.05 |
0.04 |
0.04 |
Stock adjustment |
- |
- |
- |
- |
- |
Raw material |
- |
- |
- |
- |
- |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
0.08 |
0.08 |
0.08 |
0.08 |
0.08 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
0.05 |
0.38 |
0.24 |
0.08 |
0.09 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
Taxation |
- |
- |
- |
- |
- |
Net profit / loss |
-0.07 |
0.20 |
-0.27 |
-0.12 |
-0.13 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
75.77 |
75.77 |
75.77 |
75.77 |
75.77 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
-131.11 |
-837.40 |
-595.56 |
-238.89 |
-268.89 |
GPM (%) |
-49.07 |
31.75 |
-259.31 |
-108.11 |
-123.31 |
NPM (%) |
-71.75 |
28.44 |
-283.35 |
-134.12 |
-149.32 |